Amarin NDA For CeNeS Morphine Suppository Planned For Second-Half 2002
Executive Summary
Amarin expects to file an NDA for the morphine-releasing rectal suppository Moraxen by second-half 2002.
You may also be interested in...
EU Generic Approvals Could Accelerate By Two Years With Bolar Changes
The European Commission's proposed patent reforms could accelerate the approval of generic drugs by two years.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011